CollPlant Biotechnologies Ltd. (CLGN): Price and Financial Metrics
CLGN Price/Volume Stats
| Current price | $5.24 | 52-week high | $8.90 |
| Prev. close | $5.16 | 52-week low | $4.22 |
| Day low | $5.10 | Volume | 6,600 |
| Day high | $5.25 | Avg. volume | 8,291 |
| 50-day MA | $5.26 | Dividend yield | N/A |
| 200-day MA | $5.80 | Market Cap | 60.01M |
CLGN Stock Price Chart Interactive Chart >
CollPlant Biotechnologies Ltd. (CLGN) Company Bio
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bio-printing of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. The company's products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. Its products include BioInks for 3D printing of tissues and organs; dermal filler for treating wrinkles; 3D Bioprinted breast implants; VergenixSTR, a soft tissue repair matrix intended for treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.
Latest CLGN News From Around the Web
Below are the latest news stories about COLLPLANT BIOTECHNOLOGIES LTD that investors may wish to consider to help them evaluate CLGN as an investment opportunity.
CollPlant Biotechnologies Announces Third Quarter Financial Results for 2023CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and organ manufacturing, today announced financial results for the third quarter ended September 30, 2023, and provided a corporate update on its programs. |
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATIONCollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and organ manufacturing, today announced that it will report financial results for the third quarter of 2023 on Wednesday, November 29, 2023, before the market open. The Company will then host a conference call and webcast to discuss its financial results and corporate updates on November 29 at 10 |
Will CollPlant Biotechnologies (NASDAQ:CLGN) Spend Its Cash Wisely?Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the... |
CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal FillerCollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and organ manufacturing, today announced that the U.S. Patent and Trademark Office has granted a patent that covers CollPlant's photocurable dermal filler product candidate, being developed for the aesthetics market. |
Shareholders in CollPlant Biotechnologies (NASDAQ:CLGN) are in the red if they invested three years agoMany investors define successful investing as beating the market average over the long term. But in any portfolio... |
CLGN Price Returns
| 1-mo | 0.15% |
| 3-mo | -1.13% |
| 6-mo | 1.95% |
| 1-year | -23.50% |
| 3-year | -63.84% |
| 5-year | N/A |
| YTD | -18.00% |
| 2023 | -23.47% |
| 2022 | -48.96% |
| 2021 | 51.90% |
| 2020 | 88.95% |
| 2019 | 35.71% |
Continue Researching CLGN
Want to do more research on CollPlant Biotechnologies Ltd's stock and its price? Try the links below:CollPlant Biotechnologies Ltd (CLGN) Stock Price | Nasdaq
CollPlant Biotechnologies Ltd (CLGN) Stock Quote, History and News - Yahoo Finance
CollPlant Biotechnologies Ltd (CLGN) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...